Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
Ранг среди акций #7700
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
Цена акции
$12.18
Последняя синхронизация: 2025-02-17
Рыночная капитализация
$1.49B
Изменение (1 день)
4.21%
Изменение (1 год)
0.00%
Страна
IN
Торговля Glenmark Life Sciences Limited (GLS)

Категория

История цены акций Glenmark Life Sciences Limited (GLS)
Наивысшая цена закрытия: $13.07 2025-02-01

Наименьшая цена закрытия: $9.63 2021-08-01
История цены акций Glenmark Life Sciences Limited с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2025 8.46%
2024 56.27%
2023 49.21%
2022 -36.04%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$171.67 -
DE
$165.82 32.07%
DE
$37.84 25.57%
JP
$223.44 28.17%
CH
$21.19 17.04%
IN